MedPath

Remote Ischemia Pre-Conditioning in Patients Undergoing Partial Nephrectomy

Not Applicable
Terminated
Conditions
Renal Cell Carcinoma
Interventions
Device: CellAegis' autoRIC™ Device
Registration Number
NCT01771003
Lead Sponsor
University Health Network, Toronto
Brief Summary

Partial Nephrectomy has become the standard treatment in patients with tumours \<7cm (T1). Even though this is a nephron sparing surgery, there is still potential for acute kidney injury, due to ischemia during the surgery. Remote Ischemia Preconditioning may prevent acute kidney injury and in turn chronic kidney disease. Remote Ischemia pre-conditioning involves applying a blood pressure cuff and inflating and deflating several times immediately prior to surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Patient must be a candidate for laparoscopic partial nephrectomy
  • ECOG Performance status of 0-1
Exclusion Criteria
  • No diagnosis of any current cutaneous, vascular or neural disease in the right upper arm.
  • If the patient received isoflurane for any indication during the operation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Without CellAegis' autoRIC™ DeviceCellAegis' autoRIC™ Devicepatients will have a blood pressure cuff attached to their arm that will not inflate/deflate as in the active group
With CellAegis' autoRIC™ DeviceCellAegis' autoRIC™ DevicePatients will have the CellAegis' autoRIC™ Device attached and it will inflate to 200 mmHg in four 5 minute cycles with intervening 5 minutes of reperfusion with the cuff deflated between cycles (while under general anesthetic)
Primary Outcome Measures
NameTimeMethod
Change in Kidney Function before and after surgeryup to 2 weeks prior to surgery and up to 24 hrs post surgery

To measure and compare kidney function (Cr, eGFR) and AKI biomarkers in patients undergoing partial nephrectomy with and without RIPC

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Health Network

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath